Global Transcriptomics 麻豆原创 2021-2031 by Component , Technology , Application , End User , and Region: Trend Forecast and Growth Opportunity

Publication ID:

GRM1022009

Publication Date:

October 30, 2022

Pages:

175

Publisher:

Grace 麻豆原创 Data

Countries:

Global [1]

USD 3,180.00

Oncology [2]

Therapeutic [3]

Country Overview (Pharma & Healthcare) [4]

Pharma & Healthcare [5]

Description:

Global transcriptomics market will reach $ 16,077.8 million by 2031, growing by 10.7% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure.
Highlighted with 92 tables and 79 figures, this 175-page report 鈥淕lobal Transcriptomics 麻豆原创 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire global transcriptomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global transcriptomics market in every aspect of the classification from perspectives of Component, Technology, Application, End User, and Region.

Based on Component, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Instruments
鈥� Consumables
鈥� Software
鈥� Services

Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Polymerase Chain Reaction (PCR)
鈥� Next-Generation Sequencing
鈥� Microarray
鈥� In-Situ Hybridization (ISH)
鈥� Gene Regulation Technologies
鈥� Other Technologies

By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Drug Discovery and Development
鈥� Diagnostics
鈥� Single Cell Analysis
鈥� Gene Expression
鈥� Cell Biology
鈥� Other Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Academic and Research Institutions
鈥� Biotechnology and Biopharmaceutical Companies
鈥� Contract Research Organizations (CROs)
鈥� Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
鈥� North America (U.S., Canada, and Mexico)
鈥� Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
鈥� APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
鈥� South America (Brazil, Chile, Argentina, Rest of South America)
鈥� MEA (UAE锛孲audi Arabia锛� South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Component, Technology and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
10x Genomics
Agilent Technologies, Inc.
ANGLE plc
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
BioSypder, Inc.
Bio-Techne
Cytiva
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Menarini Silicon Biosystems
Merck & Co., Inc.
NanoString
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
Promega Corporation
Qiagen N. V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of 麻豆原创 Research Methodology 13
1.2.2 麻豆原创 Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 麻豆原创 Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 麻豆原创 Overview and Dynamics 21
2.1 麻豆原创 Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the 麻豆原创 24
2.2 Major Growth Drivers 26
2.3 麻豆原创 Restraints and Challenges 31
2.4 Emerging Opportunities and 麻豆原创 Trends 34
2.5 Porter鈥檚 Fiver Forces Analysis 38
3 Segmentation of Global 麻豆原创 by Component 42
3.1 麻豆原创 Overview by Component 42
3.2 Instruments 44
3.3 Consumables 46
3.4 Software 48
3.5 Services 50
4 Segmentation of Global 麻豆原创 by Technology 51
4.1 麻豆原创 Overview by Technology 51
4.2 Polymerase Chain Reaction (PCR) 53
4.3 Next-Generation Sequencing 55
4.4 Microarray 57
4.5 In-Situ Hybridization (ISH) 59
4.6 Gene Regulation Technologies 61
4.7 Other Technologies 62
5 Segmentation of Global 麻豆原创 by Application 63
5.1 麻豆原创 Overview by Application 63
5.2 Drug Discovery and Development 65
5.3 Diagnostics 66
5.4 Single Cell Analysis 67
5.5 Gene Expression 68
5.6 Cell Biology 69
5.7 Other Applications 70
6 Segmentation of Global 麻豆原创 by End User 71
6.1 麻豆原创 Overview by End User 71
6.2 Academic and Research Institutions 73
6.3 Biotechnology and Biopharmaceutical Companies 74
6.4 Contract Research Organizations (CROs) 75
6.5 Other End Users 76
7 Segmentation of Global 麻豆原创 by Region 77
7.1 Geographic 麻豆原创 Overview 2021-2031 77
7.2 North America 麻豆原创 2021-2031 by Country 81
7.2.1 Overview of North America 麻豆原创 81
7.2.2 U.S. 85
7.2.3 Canada 88
7.2.4 Mexico 90
7.3 European 麻豆原创 2021-2031 by Country 92
7.3.1 Overview of European 麻豆原创 92
7.3.2 Germany 96
7.3.3 U.K. 98
7.3.4 France 100
7.3.5 Spain 102
7.3.6 Italy 104
7.3.7 Netherlands 106
7.3.8 Rest of European 麻豆原创 108
7.4 Asia-Pacific 麻豆原创 2021-2031 by Country 110
7.4.1 Overview of Asia-Pacific 麻豆原创 110
7.4.2 Japan 114
7.4.3 China 117
7.4.4 Australia 119
7.4.5 India 121
7.4.6 South Korea 123
7.4.7 Rest of APAC Region 125
7.5 South America 麻豆原创 2021-2031 by Country 127
7.5.1 Argentina 130
7.5.2 Brazil 132
7.5.3 Chile 134
7.5.4 Rest of South America 麻豆原创 136
7.6 MEA 麻豆原创 2021-2031 by Country 137
7.6.1 UAE 140
7.6.2 Saudi Arabia 142
7.6.3 South Africa 144
7.6.4 Other National 麻豆原创s 146
8 Competitive Landscape 147
8.1 Overview of Key Vendors 147
8.2 New Product Launch, Partnership, Investment, and M&A 152
8.3 Company Profiles 153
10x Genomics 153
Agilent Technologies, Inc. 155
ANGLE plc 156
Becton, Dickinson and Company (BD) 157
Bio-Rad Laboratories, Inc. 158
BioSypder, Inc. 159
Bio-Techne 160
Cytiva 161
F. Hoffmann-La Roche Ltd. 162
Fluidigm Corporation 163
GE Healthcare 164
Illumina, Inc. 165
Menarini Silicon Biosystems 166
Merck & Co., Inc. 167
NanoString 168
Pacific Biosciences of California, Inc. 169
PerkinElmer Inc. 170
Promega Corporation 171
Qiagen N. V. 172
Takara Bio Inc. 173
Thermo Fisher Scientific Inc. 174
RELATED REPORTS 175

Companies Mentioned:

Selected Key Players:
10x Genomics
Agilent Technologies, Inc.
ANGLE plc
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
BioSypder, Inc.
Bio-Techne
Cytiva
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Menarini Silicon Biosystems
Merck & Co., Inc.
NanoString
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
Promega Corporation
Qiagen N. V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.